Background: Radiomics has emerged as a new approach that can help identify imaging information associated with tumor pathophysiology. We developed and validated a radiomics nomogram for preoperative prediction of microvascular invasion (MVI) in hepatocellular carcinoma (HCC). Methods: Two hundred and eight patients with pathologically confirmed HCC (training cohort: n = 146; validation cohort: n = 62) who underwent preoperative gadoxetic acid-enhanced magnetic resonance (MR) imaging were included. Least absolute shrinkage and selection operator logistic regression was applied to select features and construct signatures derived from MR images. Univariate and multivariate analyses were used to identify the significant clinicoradiological variables and radiomics signatures associated with MVI, which were then incorporated into the predictive nomogram. The performance of the radiomics nomogram was evaluated by its calibration, discrimination, and clinical utility. Results: Higher α-fetoprotein level (p = 0.046), nonsmooth tumor margin (p = 0.003), arterial peritumoral enhancement (p < 0.001), and the radiomics signatures of hepatobiliary phase (HBP) T1-weighted images (p < 0.001) and HBP T1 maps (p < 0.001) were independent risk factors of MVI. The predictive model that incorporated the clinicoradiological factors and the radiomic features derived from HBP images outperformed the combination of clinicoradiological factors in the training cohort (area under the curves [AUCs] 0.943 vs. 0.850; p = 0.002), though the validation did not have a statistical significance (AUCs 0.861 vs. 0.759; p = 0.111). The nomogram based on the model exhibited C-index of 0.936 (95% CI 0.895–0.976) and 0.864 (95% CI 0.761–0.967) in the training and validation cohort, fitting well in calibration curves (p > 0.05). Decision curve analysis further confirmed the clinical usefulness of the nomogram. Conclusions: The nomogram incorporating clinicoradiological risk factors and radiomic features derived from HBP images achieved satisfactory preoperative prediction of the individualized risk of MVI in patients with HCC.

1.
Forner
A
,
Llovet
JM
,
Bruix
J
.
Hepatocellular carcinoma
.
Lancet
.
2012
Mar
;
379
(
9822
):
1245
55
.
[PubMed]
0140-6736
2.
Fujiwara
N
,
Friedman
SL
,
Goossens
N
,
Hoshida
Y
.
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
.
J Hepatol
.
2018
Mar
;
68
(
3
):
526
49
.
[PubMed]
0168-8278
3.
Llovet
JM
,
Schwartz
M
,
Mazzaferro
V
.
Resection and liver transplantation for hepatocellular carcinoma
.
Semin Liver Dis
.
2005
;
25
(
2
):
181
200
.
[PubMed]
0272-8087
4.
De Angelis
R
,
Sant
M
,
Coleman
MP
,
Francisci
S
,
Baili
P
,
Pierannunzio
D
, et al.;
EUROCARE-5 Working Group
.
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE—5-a population-based study
.
Lancet Oncol
.
2014
Jan
;
15
(
1
):
23
34
.
[PubMed]
1470-2045
5.
Mazzaferro
V
,
Bhoori
S
,
Sposito
C
,
Bongini
M
,
Langer
M
,
Miceli
R
, et al.
Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience
.
Liver Transpl
.
2011
Oct
;
17
(
S2
Suppl 2
):
S44
57
.
[PubMed]
1527-6465
6.
Hwang
S
,
Lee
YJ
,
Kim
KH
,
Ahn
CS
,
Moon
DB
,
Ha
TY
, et al.
The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients
.
J Gastrointest Surg
.
2015
Jul
;
19
(
7
):
1281
90
.
[PubMed]
1091-255X
7.
Rodríguez-Perálvarez
M
,
Luong
TV
,
Andreana
L
,
Meyer
T
,
Dhillon
AP
,
Burroughs
AK
.
A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability
.
Ann Surg Oncol
.
2013
Jan
;
20
(
1
):
325
39
.
[PubMed]
1068-9265
8.
Sumie
S
,
Nakashima
O
,
Okuda
K
,
Kuromatsu
R
,
Kawaguchi
A
,
Nakano
M
, et al.
The significance of classifying microvascular invasion in patients with hepatocellular carcinoma
.
Ann Surg Oncol
.
2014
Mar
;
21
(
3
):
1002
9
.
[PubMed]
1068-9265
9.
Shi
M
,
Guo
RP
,
Lin
XJ
,
Zhang
YQ
,
Chen
MS
,
Zhang
CQ
, et al.
Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial
.
Ann Surg
.
2007
Jan
;
245
(
1
):
36
43
.
[PubMed]
0003-4932
10.
Omata
M
,
Cheng
AL
,
Kokudo
N
,
Kudo
M
,
Lee
JM
,
Jia
J
, et al.
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
.
Hepatol Int
.
2017
Jul
;
11
(
4
):
317
70
.
[PubMed]
1936-0533
11.
Zheng
J
,
Chakraborty
J
,
Chapman
WC
,
Gerst
S
,
Gonen
M
,
Pak
LM
, et al.;
Hepatopancreatobiliary Service in the Department of Surgery of the Memorial Sloan Kettering Cancer Center
;
Research Staff in the Department of Surgery at Washington University School of Medicine
.
Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis
.
J Am Coll Surg
.
2017
Dec
;
225
(
6
):
778
788.e1
.
[PubMed]
1072-7515
12.
Renzulli
M
,
Brocchi
S
,
Cucchetti
A
,
Mazzotti
F
,
Mosconi
C
,
Sportoletti
C
, et al.
Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma?
Radiology
.
2016
May
;
279
(
2
):
432
42
.
[PubMed]
0033-8419
13.
Lee
S
,
Kim
SH
,
Lee
JE
,
Sinn
DH
,
Park
CK
.
Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma
.
J Hepatol
.
2017
Sep
;
67
(
3
):
526
34
.
[PubMed]
0168-8278
14.
Ahn
SY
,
Lee
JM
,
Joo
I
,
Lee
ES
,
Lee
SJ
,
Cheon
GJ
, et al.
Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT
.
Abdom Imaging
.
2015
Apr
;
40
(
4
):
843
51
.
[PubMed]
0942-8925
15.
Kim
JY
,
Kim
MJ
,
Kim
KA
,
Jeong
HT
,
Park
YN
.
Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features
.
Eur J Radiol
.
2012
Dec
;
81
(
12
):
3877
82
.
[PubMed]
0720-048X
16.
Kim
KA
,
Kim
MJ
,
Jeon
HM
,
Kim
KS
,
Choi
JS
,
Ahn
SH
, et al.
Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images
.
J Magn Reson Imaging
.
2012
Mar
;
35
(
3
):
629
34
.
[PubMed]
1053-1807
17.
Lambin
P
,
Leijenaar
RT
,
Deist
TM
,
Peerlings
J
,
de Jong
EE
,
van Timmeren
J
, et al.
Radiomics: the bridge between medical imaging and personalized medicine
.
Nat Rev Clin Oncol
.
2017
Dec
;
14
(
12
):
749
62
.
[PubMed]
1759-4774
18.
Bowen
SR
,
Yuh
WT
,
Hippe
DS
,
Wu
W
,
Partridge
SC
,
Elias
S
, et al.
Tumor radiomic heterogeneity: multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy
.
J Magn Reson Imaging
.
2018
May
;
47
(
5
):
1388
96
.
[PubMed]
1053-1807
19.
Kickingereder
P
,
Neuberger
U
,
Bonekamp
D
,
Piechotta
PL
,
Götz
M
,
Wick
A
, et al.
Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma
.
Neuro-oncol
.
2018
May
;
20
(
6
):
848
57
.
[PubMed]
1522-8517
20.
Zhang
B
,
Tian
J
,
Dong
D
,
Gu
D
,
Dong
Y
,
Zhang
L
, et al.
Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma
.
Clin Cancer Res
.
2017
Aug
;
23
(
15
):
4259
69
.
[PubMed]
1078-0432
21.
Huang
Y
,
Liu
Z
,
He
L
,
Chen
X
,
Pan
D
,
Ma
Z
, et al.
Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer
.
Radiology
.
2016
Dec
;
281
(
3
):
947
57
.
[PubMed]
0033-8419
22.
Choi
JW
,
Lee
JM
,
Kim
SJ
,
Yoon
JH
,
Baek
JH
,
Han
JK
, et al.
Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker
.
Radiology
.
2013
Jun
;
267
(
3
):
776
86
.
[PubMed]
0033-8419
23.
Kitao
A
,
Matsui
O
,
Yoneda
N
,
Kozaka
K
,
Kobayashi
S
,
Koda
W
, et al.
Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images
.
Radiology
.
2012
Dec
;
265
(
3
):
780
9
.
[PubMed]
0033-8419
24.
Cong
WM
,
Bu
H
,
Chen
J
,
Dong
H
,
Zhu
YY
,
Feng
LH
, et al.;
Guideline Committee
.
Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update
.
World J Gastroenterol
.
2016
Nov
;
22
(
42
):
9279
87
.
[PubMed]
1007-9327
25.
Lei
Z
,
Li
J
,
Wu
D
,
Xia
Y
,
Wang
Q
,
Si
A
, et al.
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria
.
JAMA Surg
.
2016
Apr
;
151
(
4
):
356
63
.
[PubMed]
2168-6254
26.
Aerts
HJ
,
Velazquez
ER
,
Leijenaar
RT
,
Parmar
C
,
Grossmann
P
,
Carvalho
S
, et al.
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
.
Nat Commun
.
2014
Jun
;
5
(
1
):
4006
.
[PubMed]
2041-1723
27.
Thibault
G
,
Fertil
B
,
Navarro
C
,
Pereira
S
,
Cau
P
,
Levy
N
, et al.
Shape and Texture Indexes Application to Cell Nuclei Classification
.
Int J Pattern Recognit Artif Intell
.
2013
;
27
(
01
):
1357002
. 0218-0014
28.
Galloway
MM
.
Texture analysis using grey level run lengths.
NASA STI/Recon Technical Report N
1974
;75
29.
Amadasun
M
,
King
R
.
Textural features corresponding to textural properties
.
IEEE Trans Syst Man Cybern
.
1989
;
19
(
5
):
1264
74
. 0018-9472
30.
Tibshirani
R
.
The lasso method for variable selection in the Cox model
.
Stat Med
.
1997
Feb
;
16
(
4
):
385
95
.
[PubMed]
0277-6715
31.
Sauerbrei
W
,
Royston
P
,
Binder
H
.
Selection of important variables and determination of functional form for continuous predictors in multivariable model building
.
Stat Med
.
2007
Dec
;
26
(
30
):
5512
28
.
[PubMed]
0277-6715
32.
Uno
H
,
Cai
T
,
Pencina
MJ
,
D’Agostino
RB
,
Wei
LJ
.
On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data
.
Stat Med
.
2011
May
;
30
(
10
):
1105
17
.
[PubMed]
0277-6715
33.
Balachandran
VP
,
Gonen
M
,
Smith
JJ
,
DeMatteo
RP
.
Nomograms in oncology: more than meets the eye
.
Lancet Oncol
.
2015
Apr
;
16
(
4
):
e173
80
.
[PubMed]
1470-2045
34.
Kramer
AA
,
Zimmerman
JE
.
Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited
.
Crit Care Med
.
2007
Sep
;
35
(
9
):
2052
6
.
[PubMed]
0090-3493
35.
Vickers
AJ
,
Elkin
EB
.
Decision curve analysis: a novel method for evaluating prediction models
.
Med Decis Making
.
2006
Nov-Dec
;
26
(
6
):
565
74
.
[PubMed]
0272-989X
36.
Haimerl
M
,
Verloh
N
,
Zeman
F
,
Fellner
C
,
Nickel
D
,
Lang
SA
, et al.
Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: comparison between signal-intensity-based indices and T1 relaxometry
.
Sci Rep
.
2017
Mar
;
7
(
1
):
43347
.
[PubMed]
2045-2322
37.
Hu
H
,
Zheng
Q
,
Huang
Y
,
Huang
XW
,
Lai
ZC
,
Liu
J
, et al.
A non-smooth tumor margin on preoperative imaging assesses microvascular invasion of hepatocellular carcinoma: A systematic review and meta-analysis
.
Sci Rep
.
2017
Nov
;
7
(
1
):
15375
.
[PubMed]
2045-2322
38.
Wang
WT
,
Yang
L
,
Yang
ZX
,
Hu
XX
,
Ding
Y
,
Yan
X
, et al.
Assessment of Microvascular Invasion of Hepatocellular Carcinoma with Diffusion Kurtosis Imaging
.
Radiology
.
2018
Feb
;
286
(
2
):
571
80
.
[PubMed]
0033-8419
39.
Cucchetti
A
,
Piscaglia
F
,
Grigioni
AD
,
Ravaioli
M
,
Cescon
M
,
Zanello
M
, et al.
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study
.
J Hepatol
.
2010
Jun
;
52
(
6
):
880
8
.
[PubMed]
0168-8278
40.
Hui
AM
,
Takayama
T
,
Sano
K
,
Kubota
K
,
Akahane
M
,
Ohtomo
K
, et al.
Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy
.
J Hepatol
.
2000
Dec
;
33
(
6
):
975
9
.
[PubMed]
0168-8278
41.
Sumie
S
,
Kuromatsu
R
,
Okuda
K
,
Ando
E
,
Takata
A
,
Fukushima
N
, et al.
Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors
.
Ann Surg Oncol
.
2008
May
;
15
(
5
):
1375
82
.
[PubMed]
1068-9265
42.
Banerjee
S
,
Wang
DS
,
Kim
HJ
,
Sirlin
CB
,
Chan
MG
,
Korn
RL
, et al.
A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma
.
Hepatology
.
2015
Sep
;
62
(
3
):
792
800
.
[PubMed]
0270-9139
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.